Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Reata Pharmaceuticals First Quarter 2021 Financial Results and Update on Development Programs Conference Call. An audio recording of today s webcast will be available shortly after the call today on Reata s website at reatapharma.com in the Investors section. Before the company proceeds with its remarks, please note the forward-looking statements disclosure in the company s press release. The company will be making forward-looking statements on today s call. There are many factors that could cause results to differ from expectations, including those noted in the company s SEC filings. On today s conference call, non-GAAP financial measures will be used to help investors understand the business performance.
Operator
Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2021 Earnings Conference Call. As a reminder, this conference call is being recorded at the company s request.
I will now turn the call over to your host, Will Grammig of Stern IR. Please go ahead.
Lauren Stival
Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s first quarter 2021 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com.